Evidence-Based Clinical Infusion Therapy Safety Protocols
Real-time bedside monitoring, pharmacovigilance telemetry, and acute complication response uniting oncology physicians, certified infusion nurses, and sterile compounding pharmacists.
1. Infusion Safety Command Console
2. Telemetry Workspace & Rescue Matrix
| Agent | Concentration | Max Rate | Monitoring |
|---|---|---|---|
| Vancomycin | 1 g / 250 mL | ≤ 10 mg/min | Trough level, Red Man |
| Amiodarone | 150 mg / 100 mL | ≤ 1 mg/min | Continuous ECG, BP |
| Potassium Cl | 10 mEq / 100 mL | ≤ 10 mEq/hr | Telemetry, vein burn |
| Vasopressin | 20 U / 100 mL | ≤ 0.04 U/min | MAP, peripheral status |
Compare your symptoms to learn what's normal — and what to watch for.
Let's find out what's going on. Follow the steps below.
Our accredited clinical team (CRNI®, PharmD, MD Oncology) is here to guide patients and clinicians through infusion complications, questions, and emergency protocols.
4. Clinical Knowledge Pillars & Practice Standards
Our clinical guidance is organized across 8 core topical pillars synthesized from the Infusion Nurses Society (INS) 2024 Standards, CDC intravascular infection guidelines, and USP sterile compounding mandates:
Clinical Safety Standards
Extravasation antidotes, CDC CLABSI bundles, USP <800> CSTD, in-line filtration, sharps protection, and air embolism resuscitation.
High-Alert Therapies Hub
Evidence-based protocols for IV Iron CARPA triage, IVIG 4-step rate titration, infliximab reconstitution, and chemotherapy independent double-checks.
Home Infusion Care
PICC line sterile dressings, Celsite® titanium port Huber needle mechanics, and 2 AM caregiver crisis decision algorithms.
Patient Resources
Patient symptom checker, 10 essential questions to ask your care team, and bedside medication verification aids.
Provider Standards
INS 2024 Standards of Practice, CDC CLABSI guidelines, and USP <797>/<800> sterile compounding cleanroom mandates.
Medical Review Board
Board-certified clinical specialists (CRNI, PharmD, MD Oncology) overseeing editorial rigor and evidence integrity.
Clinical Consultations
Direct communications with our editorial review board for healthcare systems, vascular access teams, and patients.
Clinical Evidence FAQ
Peer-reviewed answers to clinical inquiries regarding vascular access dwell times, line locks, and filtration thresholds.
5. Multi-Disciplinary Clinical Governance
Every clinical protocol, guideline, and decision matrix published on Safe Infusion Therapy undergoes multi-disciplinary peer review by our accredited board:
Editorial & Clinical Review Leadership:
- Sarah Jenkins, MSN, RN, CRNI®, VA-BC™ (Board Chair): Lead Infusion Nursing Specialist with 18+ years acute vascular access leadership and INS Standards expertise.
- Arthur Vance, MD, FACP: Senior Clinical Oncology & Pharmacology Advisor with 22+ years experience in high-alert chemotherapy administration and extravasation antidotes.
- Marcus Finch, PharmD, BCPPS, BCSCP: Compounding Pharmacy & Drug Compatibility Specialist directing ISO Class 7 cleanroom operations under USP <797>/<800>.